{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:46:07Z","timestamp":1791978367852,"version":"4.4.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.tips.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T01:15:30Z","timestamp":1376961330000},"page":"489-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":400,"title":["Mechanisms of dopamine transporter regulation in normal and disease states"],"prefix":"10.1016","volume":"34","author":[{"given":"Roxanne A.","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2013.07.005_bib0005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1208\/s12248-012-9391-0","article-title":"Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective","volume":"14","author":"Manepalli","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.tips.2013.07.005_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","article-title":"SLC6 transporters: structure, function, regulation, disease association and therapeutics","volume":"34","author":"Pramod","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.tips.2013.07.005_bib0015","doi-asserted-by":"crossref","first-page":"e16350","DOI":"10.1371\/journal.pone.0016350","article-title":"The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter","volume":"6","author":"Shan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2013.07.005_bib0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn920","article-title":"Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons","volume":"5","author":"Ingram","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0030","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.0403299101","article-title":"Dopamine transporters depolarize neurons by a channel mechanism","volume":"101","author":"Carvelli","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.07.005_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse","volume":"1187","author":"Schmitt","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2013.07.005_bib0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pharmthera.2010.09.009","article-title":"Regulation of monoamine transporters: role of transporter phosphorylation","volume":"129","author":"Ramamoorthy","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2013.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1124\/mol.106.026120","article-title":"A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter\/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function","volume":"70","author":"Beuming","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl--dependent neurotransmitter transporters","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.07.005_bib0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.110.069039","article-title":"Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters","volume":"79","author":"Guptaroy","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/mol.108.048744","article-title":"A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation","volume":"75","author":"Guptaroy","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0065","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1074\/jbc.M109.083154","article-title":"The N terminus of monoamine transporters is a lever required for the action of amphetamines","volume":"285","author":"Sucic","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0070","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1074\/jbc.M200294200","article-title":"Dopamine transporters are phosphorylated on N-terminal serines in rat striatum","volume":"277","author":"Foster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0075","doi-asserted-by":"crossref","first-page":"40442","DOI":"10.1074\/jbc.M501969200","article-title":"Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms","volume":"280","author":"Cervinski","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2003.08.059","article-title":"The effect of phosphorylation on amphetamine-mediated outward transport","volume":"479","author":"Gnegy","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1074\/jbc.M112.407874","article-title":"Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding","volume":"288","author":"Moritz","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0090","doi-asserted-by":"crossref","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","article-title":"Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux","volume":"287","author":"Foster","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/bi801696n","article-title":"Proline-directed phosphorylation of the dopamine transporter N-terminal domain","volume":"48","author":"Gorentla","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2013.07.005_bib0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0962-8924(02)02253-5","article-title":"Pinning down proline-directed phosphorylation signaling","volume":"12","author":"Lu","year":"2002","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tips.2013.07.005_bib0105","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.febslet.2012.04.042","article-title":"SH3 domain ligand binding: what's the consensus and where's the specificity?","volume":"586","author":"Saksela","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2013.07.005_bib0110","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1074\/jbc.M109.058990","article-title":"Lysine 63-linked polyubiquitination of the dopamine transporter requires WW3 and WW4 domains of Nedd4-2 and UBE2D ubiquitin-conjugating enzymes","volume":"285","author":"Vina-Vilaseca","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1091\/mbc.E06-08-0704","article-title":"Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter","volume":"18","author":"Miranda","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tips.2013.07.005_bib0120","doi-asserted-by":"crossref","first-page":"54380","DOI":"10.1074\/jbc.M409282200","article-title":"Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter","volume":"279","author":"Jiang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0125","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1096\/fj.12-218727","article-title":"Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons","volume":"27","author":"Hong","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2013.07.005_bib0130","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1074\/jbc.M110.187872","article-title":"Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation","volume":"286","author":"Foster","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mcn.2008.06.011","article-title":"Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization","volume":"39","author":"Boudanova","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0140","doi-asserted-by":"crossref","first-page":"13758","DOI":"10.1523\/JNEUROSCI.2649-11.2011","article-title":"The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking","volume":"31","author":"Navaroli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0145","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1073\/pnas.0802214105","article-title":"Dopamine transporter\/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission","volume":"105","author":"Carvelli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.108.048447","article-title":"Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux","volume":"74","author":"Binda","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0155","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/sj.emboj.7601656","article-title":"Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2013.07.005_bib0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","article-title":"Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport","volume":"51","author":"Fog","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.07.005_bib0165","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1096\/fj.00-0334com","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2013.07.005_bib0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12031-007-0037-0","article-title":"Parkin disrupts the alpha-synuclein\/dopamine transporter interaction: consequences toward dopamine-induced toxicity","volume":"32","author":"Moszczynska","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nn.2781","article-title":"Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT","volume":"14","author":"Cremona","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","article-title":"The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders","volume":"69","author":"Tejeda","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2013.07.005_bib0185","doi-asserted-by":"crossref","first-page":"e59788","DOI":"10.1371\/journal.pone.0059788","article-title":"Inhibition of dopamine transporter activity by G protein betagamma subunits","volume":"8","author":"Garcia-Olivares","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2013.07.005_bib0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/fnl.09.76","article-title":"Dopamine transporter trafficking: rapid response on demand","volume":"5","author":"Chen","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.tips.2013.07.005_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1471-4159.2010.06599.x","article-title":"Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges","volume":"113","author":"Eriksen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0200","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1523\/JNEUROSCI.19-18-07699.1999","article-title":"Membrane trafficking regulates the activity of the human dopamine transporter","volume":"19","author":"Melikian","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0205","doi-asserted-by":"crossref","first-page":"35794","DOI":"10.1074\/jbc.274.50.35794","article-title":"Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters","volume":"274","author":"Daniels","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/tra.12059","article-title":"Flotillins regulate membrane mobility of the dopamine transporter but are not required for its protein kinase C dependent endocytosis","volume":"14","author":"Sorkina","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.tips.2013.07.005_bib0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0854.2005.00259.x","article-title":"Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism","volume":"6","author":"Sorkina","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.tips.2013.07.005_bib0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mcn.2010.08.016","article-title":"Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons","volume":"46","author":"Rao","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0225","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1074\/jbc.M205058200","article-title":"N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization","volume":"278","author":"Granas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0230","doi-asserted-by":"crossref","first-page":"22168","DOI":"10.1074\/jbc.M301845200","article-title":"The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines","volume":"278","author":"Loder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0235","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.2008.05262.x","article-title":"Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol","volume":"105","author":"Foster","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuropharm.2005.08.012","article-title":"Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala","volume":"49","author":"Mazei-Robison","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2013.07.005_bib0245","series-title":"Reciprocal Phosphorylation and Palmitoylation of the Dopamine Transporter Regulate Transport Capacity","author":"Moritz","year":"2011"},{"key":"10.1016\/j.tips.2013.07.005_bib0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(99)00828-6","article-title":"Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes","volume":"389","author":"Cowell","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0255","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-4159.2010.06788.x","article-title":"PKC links Gq-coupled receptors to DAT-mediated dopamine release","volume":"114","author":"Opazo","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0260","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1523\/JNEUROSCI.23-24-08480.2003","article-title":"Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity","volume":"23","author":"Moron","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0265","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1074\/jbc.M611758200","article-title":"Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors","volume":"282","author":"Zapata","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0270","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/mol.106.027763","article-title":"D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism","volume":"71","author":"Bolan","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0275","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","article-title":"Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","volume":"20","author":"Thompson","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0280","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/syn.20648","article-title":"Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia","volume":"63","author":"Lee","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.tips.2013.07.005_bib0285","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jnc.12229","article-title":"Protein kinase Cbeta is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter","volume":"125","author":"Chen","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2010.07.025","article-title":"Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression","volume":"170","author":"Cervinski","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2013.07.005_bib0295","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1523\/JNEUROSCI.4559-08.2009","article-title":"Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3","volume":"29","author":"Egana","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0300","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1074\/jbc.M109.054510","article-title":"A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles","volume":"285","author":"Cartier","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0305","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function","volume":"47","author":"Pike","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2013.07.005_bib0310","doi-asserted-by":"crossref","first-page":"32616","DOI":"10.1074\/jbc.M110.150565","article-title":"Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0315","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1021\/bi700429z","article-title":"Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching","volume":"46","author":"Adkins","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2013.07.005_bib0320","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.12007","article-title":"Importance of cholesterol in dopamine transporter function","volume":"123","author":"Jones","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0325","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbamem.2008.03.016","article-title":"Proteins and cholesterol-rich domains","volume":"1778","author":"Epand","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2013.07.005_bib0330","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2013.07.005_bib0335","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s11064-007-9521-8","article-title":"Molecular genetics of monoamine transporters: relevance to brain disorders","volume":"33","author":"Haddley","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2013.07.005_bib0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1471-4159.2002.00820.x","article-title":"Dopamine transport function is elevated in cocaine users","volume":"81","author":"Mash","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0345","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.psc.2012.03.011","article-title":"Neurobiology of addiction: insight from neurochemical imaging","volume":"35","author":"Urban","year":"2012","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.tips.2013.07.005_bib0350","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuropharm.2005.08.011","article-title":"Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation","volume":"49","author":"Gorentla","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2013.07.005_bib0355","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M413887200","article-title":"Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta","volume":"280","author":"Johnson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0360","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.108.147959","article-title":"Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice","volume":"328","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2013.07.005_bib0365","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1471-4159.2009.05910.x","article-title":"Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens","volume":"108","author":"Richards","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0370","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1073\/pnas.110035297","article-title":"Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism","volume":"97","author":"Saunders","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.07.005_bib0375","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1471-4159.2012.07875.x","article-title":"Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization","volume":"123","author":"German","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0380","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuropharm.2007.11.007","article-title":"Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent","volume":"54","author":"Boudanova","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2013.07.005_bib0385","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/syn.21506","article-title":"Methamphetamine self-administration acutely decreases monoaminergic transporter function","volume":"66","author":"McFadden","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.tips.2013.07.005_bib0390","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1523\/JNEUROSCI.21-04-01413.2001","article-title":"Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model","volume":"21","author":"Sandoval","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0395","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2008.05.028","article-title":"Differential regional effects of methamphetamine on dopamine transport","volume":"590","author":"Chu","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.07.005_bib0400","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","article-title":"How addictive drugs disrupt presynaptic dopamine neurotransmission","volume":"69","author":"Sulzer","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.07.005_bib0405","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1074\/jbc.M805298200","article-title":"Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo","volume":"284","author":"Goodwin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0410","doi-asserted-by":"crossref","first-page":"29627","DOI":"10.1074\/jbc.M112.367219","article-title":"Ca(2+)\/calmodulin-dependent protein kinase IIalpha (alphaCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome","volume":"287","author":"Steinkellner","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0415","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2013.07.005_bib0420","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1471-4159.2009.06474.x","article-title":"The reverse operation of Na(+)\/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango","volume":"112","author":"Sitte","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0425","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2011.07335.x","article-title":"Dopamine release mediated by the dopamine transporter, facts and consequences","volume":"118","author":"Leviel","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.07.005_bib0430","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","article-title":"Anomalous dopamine release associated with a human dopamine transporter coding variant","volume":"28","author":"Mazei-Robison","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.mp.4000711","article-title":"Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1)","volume":"5","author":"Grunhage","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2013.07.005_bib0440","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.pharmtox.47.120505.105242","article-title":"The functional impact of SLC6 transporter genetic variation","volume":"47","author":"Hahn","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2013.07.005_bib0445","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.5094-09.2010","article-title":"Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder","volume":"30","author":"Bowton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0450","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1523\/JNEUROSCI.6033-11.2012","article-title":"Attention deficit\/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation","volume":"32","author":"Sakrikar","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0455","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.07.005_bib0460","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.tpj.6500169","article-title":"Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities","volume":"3","author":"Lin","year":"2003","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.tips.2013.07.005_bib0465","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1866-1955-4-19","article-title":"Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings","volume":"4","author":"Dichter","year":"2012","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.tips.2013.07.005_bib0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","article-title":"Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes","volume":"34","author":"Mabb","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2013.07.005_bib0475","doi-asserted-by":"crossref","first-page":"43933","DOI":"10.1074\/jbc.M111.241232","article-title":"alpha-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter","volume":"286","author":"Swant","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.07.005_bib0480","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.febslet.2011.03.009","article-title":"Synuclein modulation of monoamine transporters","volume":"585","author":"Oaks","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2013.07.005_bib0485","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2012.04.014","article-title":"From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease","volume":"1476","author":"Bellucci","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.tips.2013.07.005_bib0490","first-page":"1595","article-title":"Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia","volume":"119","author":"Kurian","year":"2009","journal-title":"J. Clin. Invest."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471300134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471300134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T07:47:04Z","timestamp":1563695224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561471300134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S016561471300134X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2013.07.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of dopamine transporter regulation in normal and disease states","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}